GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET FORECAST 2018-2026

GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET FORECAST 2018-2026

  • October 2018 •
  • 143 pages •
  • Report ID: 5586178 •
  • Format: PDF
KEY FINDINGS
The global bone graft and substitute market is projected to increase between the forecast years of 2018-2026 at a CAGR of 5.25%. Factors like high demand for orthopaedic procedures, technological advancements and unhealthy lifestyle choices leading to a rise in degenerative joint diseases are boosting the market growth.

MARKET INSIGHTS
The global bone graft and substitute market is segmented on the basis of applications, types, and harvesting and fixation devices.The market finds its application in treatments involving long bone, spinal fusion, craniomaxillofacial, foot and ankle, dental, and joint reconstruction.

The bone graft and substitute types include autografts, allografts, and synthetics and additives. The harvesting and fixation devices are further sub-divided into implant holder, synthes RIA, platelet concentrate system, bone marrow aspirate concentrate systems, trephine attachment tool, and other harvest devices.

REGIONAL INSIGHTS
The global bone graft and substitutes market is regionally segmented into North America, Asia-Pacific, Europe and Rest of World.The Asia-Pacific market is anticipated to be the fastest-growing market, driven by rising incidences of osteoporosis and osteoarthritis and a growing number of hip and knee replacement surgeries.

However, the North American region is expected to lead the global bone graft and substitute market by the end of the forecast period on account of the high incidences of bone fractures requiring bone grafting treatment.

COMPETITIVE INSIGHTS
Some of the competing companies in the market include Allosource Inc, Baxter International Inc, Depuy Synthes Inc, Integra Lifesciences Corp, Medtronic, Nuvasive Inc, Orthofix Holdings Inc, Sigmagraft, Smith And Nephew Plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Wright Medical Group N.V and Xtant Medical Holdings Inc.